Cancer Trials Ireland   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Dublin Ireland (1996)

Organization Overview

First Clinical Trial
2005
NCT00955435
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Cancer Trials Ireland

Active Ingredients

Drugs in Phase 3 Trials (18)

bleomycin (blenoxane) (1 trial)

capecitabine (xeloda) (4 trials)

carboplatin (paraplatin) (2 trials)

cisplatin (platinol) (3 trials)

darolutamide (Nubeqa) (1 trial)

enzalutamide (xtandi) (5 trials)

epirubicin (ellence) (4 trials)

etoposide (vepesid) (2 trials)

Filgrastim (neupogen) (2 trials)

fluorouracil (efudex) (1 trial)

ibrutinib (imbruvica) (1 trial)

lapatinib (tykerb) (5 trials)

obinutuzumab (gazyva) (1 trial)

paclitaxel (taxol) (3 trials)

radium-223 (xofigo) (2 trials)

sargramostim (leukine) (1 trial)

trastuzumab (herceptin) (4 trials)

venetoclax (venclexta) (1 trial)

Drugs in Phase 2 Trials (21)

abiraterone (zytiga) (1 trial)

bortezomib (velcade) (5 trials)

cyclophosphamide (cytoxan) (4 trials)

denosumab (prolia) (1 trial)

dexamethasone (2 trials)

docetaxel (taxotere) (4 trials)

doxorubicin (Doxil) (2 trials)

fludarabine (fludara) (1 trial)

fludeoxyglucose f-18 (1 trial)

gemcitabine (gemzar) (2 trials)

Isatuximab (Sarclisa) (1 trial)

lenalidomide (revlimid) (2 trials)

nilotinib (tasigna) (1 trial)

oxaliplatin (eloxatin) (1 trial)

paricalcitol (zemplar) (1 trial)

pazopanib (votrient) (1 trial)

prednisone (meticorten) (1 trial)

rituximab (rituxan) (1 trial)

sorafenib (nexavar) (1 trial)

sulindac (clinoril) (1 trial)

urea (3 trials)

Drugs in Phase 1 Trials (6)

copanlisib (aliqopa) (2 trials)

daratumumab (darzalex) (2 trials)

lithium (lithonate) (1 trial)

panobinostat (farydak) (1 trial)

pomalidomide (pomalyst) (1 trial)

trastuzumab emtansine (kadcyla) (1 trial)

Drugs in Other Trials (2)

bevacizumab (avastin) (1 trial)

bicalutamide (casodex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 3)

Bone Marrow Diseases (Phase 2)

Bone Neoplasms (Phase 2)

Breast Neoplasms (Phase 3)

Carcinoma (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Colorectal Neoplasms (Phase 1)

Esophageal Neoplasms (Phase 3)

Leukemia (Phase 3)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)

Leukemia, Lymphoid (Phase 3)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Chronic-Phase (Phase 2)

Lung Neoplasms (Phase 2)

Melanoma (Phase 2)

Mesothelioma (Phase 2)

Multiple Myeloma (Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 1)

Neoplasms, Germ Cell and Embryonal (Phase 3)

Neoplasms, Plasma Cell (Phase 2)

Neoplasms, Second Primary (Phase 2)

Pancreatic Neoplasms (Phase 2)

Plasmacytoma (Phase 2)

Prostatic Neoplasms (Phase 3)

Small Cell Lung Carcinoma (Phase 1)

Stomach Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 37
  • # of Trial APIs: 47